In line with the limiting effects of BAG3 on tumor growth in vivo,16 tumors of BAG3‐depleted U251 cells displayed a pronounced decrease in size increases over time (~3 weeks), while ABT‐737 treatment led to the complete elimination of U251‐BAG3 KO tumors. The gene discussed is BAG3; the disease is neoplasm.